Literature DB >> 18378611

Left ventricular systolic function and outcome after in-hospital cardiac arrest.

Maria M Gonzalez1, Robert A Berg, Vinay M Nadkarni, Caio B Vianna, Karl B Kern, Sergio Timerman, Jose A Ramires.   

Abstract

BACKGROUND: The effect of prearrest left ventricular ejection fraction (LVEF) on outcome after cardiac arrest is unknown. METHODS AND
RESULTS: During a 26-month period, Utstein-style data were prospectively collected on 800 consecutive inpatient adult index cardiac arrests in an observational, single-center study at a tertiary cardiac care hospital. Prearrest echocardiograms were performed on 613 patients (77%) at 11+/-14 days before the cardiac arrest. Outcomes among patients with normal or nearly normal prearrest LVEF (> or = 45%) were compared with those of patients with moderate or severe dysfunction (LVEF < 45%) by chi(2) and logistic regression analyses. Survival to discharge was 19% in patients with normal or nearly normal LVEF compared with 8% in those with moderate or severe dysfunction (adjusted odds ratio, 4.8; 95% confidence interval, 2.3 to 9.9; P<0.001) but did not differ with regard to sustained return of spontaneous circulation (59% versus 56%; P=0.468) or 24-hour survival (39% versus 36%; P=0.550). Postarrest echocardiograms were performed on 84 patients within 72 hours after the index cardiac arrest; the LVEF decreased 25% in those with normal or nearly normal prearrest LVEF (60+/-9% to 45+/-14%; P<0.001) and decreased 26% in those with moderate or severe dysfunction (31+/-7% to 23+/-6%, P<0.001). For all patients, prearrest beta-blocker treatment was associated with higher survival to discharge (33% versus 8%; adjusted odds ratio, 3.9; 95% confidence interval, 1.8 to 8.2; P<0.001).
CONCLUSIONS: Moderate and severe prearrest left ventricular systolic dysfunction was associated with substantially lower rates of survival to hospital discharge compared with normal or nearly normal function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378611     DOI: 10.1161/CIRCULATIONAHA.107.740167

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Cardiopulmonary resuscitation and management of cardiac arrest.

Authors:  Jerry P Nolan; Jasmeet Soar; Volker Wenzel; Peter Paal
Journal:  Nat Rev Cardiol       Date:  2012-06-05       Impact factor: 32.419

2.  Right ventricular dysfunction after resuscitation predicts poor outcomes in cardiac arrest patients independent of left ventricular function.

Authors:  Vimal Ramjee; Anne V Grossestreuer; Yuan Yao; Sarah M Perman; Marion Leary; James N Kirkpatrick; Paul R Forfia; Daniel M Kolansky; Benjamin S Abella; David F Gaieski
Journal:  Resuscitation       Date:  2015-08-28       Impact factor: 5.262

3.  Akt1 genetic deficiency limits hypothermia cardioprotection following murine cardiac arrest.

Authors:  David G Beiser; Kimberly R Wojcik; Danhong Zhao; Gerasim A Orbelyan; Kimm J Hamann; Terry L Vanden Hoek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

4.  Sodium nitroprusside enhanced cardiopulmonary resuscitation prevents post-resuscitation left ventricular dysfunction and improves 24-hour survival and neurological function in a porcine model of prolonged untreated ventricular fibrillation.

Authors:  Jason Schultz; Nicolas Segal; James Kolbeck; Emily Caldwell; Marit Thorsgard; Scott McKnite; Tom P Aufderheide; Keith G Lurie; Demetris Yannopoulos
Journal:  Resuscitation       Date:  2011-12       Impact factor: 5.262

5.  Prevalence and Outcomes of Pediatric In-Hospital Cardiac Arrest Associated With Pulmonary Hypertension.

Authors:  Ryan W Morgan; Alexis A Topjian; Yan Wang; Natalie J Atkin; Todd J Kilbaugh; Francis X McGowan; Robert A Berg; Laura Mercer-Rosa; Robert M Sutton; Adam S Himebauch
Journal:  Pediatr Crit Care Med       Date:  2020-04       Impact factor: 3.624

6.  Nitrite therapy is neuroprotective and safe in cardiac arrest survivors.

Authors:  Cameron Dezfulian; Aleksey Alekseyenko; Kunjan R Dave; Ami P Raval; Rose Do; Francis Kim; Miguel A Perez-Pinzon
Journal:  Nitric Oxide       Date:  2012-03-30       Impact factor: 4.427

7.  Genetic deletion of NOS3 increases lethal cardiac dysfunction following mouse cardiac arrest.

Authors:  David G Beiser; Gerasim A Orbelyan; Brendan T Inouye; James G Costakis; Kimm J Hamann; Elizabeth M McNally; Terry L Vanden Hoek
Journal:  Resuscitation       Date:  2010-10-16       Impact factor: 5.262

8.  Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I.

Authors:  Cameron Dezfulian; Sruti Shiva; Aleksey Alekseyenko; Akshay Pendyal; D G Beiser; Jeeva P Munasinghe; Stasia A Anderson; Christopher F Chesley; T L Vanden Hoek; Mark T Gladwin
Journal:  Circulation       Date:  2009-08-24       Impact factor: 29.690

9.  Myocardial dysfunction after out-of-hospital cardiac arrest: predictors and prognostic implications.

Authors:  Yuan Yao; Nicholas James Johnson; Sarah Muirhead Perman; Vimal Ramjee; Anne Victoria Grossestreuer; David Foster Gaieski
Journal:  Intern Emerg Med       Date:  2017-10-05       Impact factor: 3.397

Review 10.  Evidence-Based Approach to Out-of-Hospital Cardiac Arrest.

Authors:  Mohammad Amin Kashef; Amir S Lotfi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.